Skip to Main Content

Paper Details

Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.
Radiology
20
2018
MK-3475, Non-Small Cell Lung Cancer, PD-L1, Programmed Cell Death Ligand-1, non-small cell lung cancer, patients, pneumothorax, programmed cell death ligand-1
Author NameAffiliation
Scott GenshaftUniversity of California Los Angeles
Fereidoun AbtinUniversity of California Los Angeles
Carlos AdameUniversity of California Los Angeles
Carlos AdameUniversity of California Los Angeles
Brian WolfUniversity of California Los Angeles
Brian WolfUniversity of California Los Angeles
Edward B GaronUniversity of California Los Angeles
Edward B GaronUniversity of California Los Angeles
Jonathan W GoldmanUniversity of California Los Angeles
Jonathan W GoldmanUniversity of California Los Angeles
Robert D SuhUniversity of California Los Angeles
  • 1 - 11

Datasets

Release 1.2